DOSSIER · 13F-HR · Q1 2026

Remedium Capital Partners, LLC

$281M in tracked AUM across 6 positions as of Q1 2026.

RC
CIK 0002104501 · last filed Mar 31, 2026
Total AUM
$281M
as of Q1 2026
Holdings
6
positions
Whale Score
66
66
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Remedium Capital Partners, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
ORKA
Oruka Therapeutics Inc
$77M1.6M27.3%
02
SYRE
Spyre Therapeutics Inc
$73M1.5M26.1%
03
GLTO
Damora Therapeutics Inc
$53M2.0M18.8%
04
APGE
Apogee Therapeutics Inc
$49M584K17.5%
05
JBIO
Jade Biosciences Inc
$22M1.6M7.9%
06
38000Q201
Crescent Biopharma Inc
$7M361K2.4%

Filing history

2026Q1Mar 31
$281M 65.2%
6 positionsView →
2025Q4Dec 31
$170M
6 positionsView →